Desjardins Global Asset Management’s Edwards Lifesciences EW Stock Holding History

Desjardins Global Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$126K	Sell	1,658 -946	-36%	-$65.8K	0.01%	426
2023 Q3	$180K	Sell	2,604 -2,049	-44%	-$165K	0.02%	389
2023 Q2	$439K	Buy	4,653 +93	+2%	+$8.08K	0.05%	312
2023 Q1	$377K	Buy	4,560 +2,631	+136%	+$207K	0.05%	305
2022 Q4	$143K	Sell	1,929 -1,983	-51%	-$153K	0.02%	371
2022 Q3	$323K	Hold	3,912	–	–	0.04%	282
2022 Q2	$371K	Sell	3,912 -1,569	-29%	-$162K	0.05%	271
2022 Q1	$644K	Sell	5,481 -114	-2%	-$12.8K	0.06%	233
2021 Q4	$725K	Buy	+5,595	New	+$653K	0.06%	237

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Desjardins Global Asset Management's EW Position: Q4 2023 in Review

Desjardins Global Asset Management reduced its Edwards Lifesciences (EW) stake by 36% in Q4 2023, selling an estimated $65.8K and leaving 1,658 shares worth $126K. The position accounts for 0.01% of the portfolio, ranked #426.

Desjardins Global Asset Management first reported a position in EW in Q4 2021 and has held it in 9 quarters since. The position peaked at $725K in Q4 2021. 1,244 funds tracked by Wall St. Rank hold EW as of Q4 2023.

Desjardins Global Asset Management held 1,658 shares of Edwards Lifesciences worth $126K as of Q4 2023.
Desjardins Global Asset Management sold 946 Edwards Lifesciences shares in Q4 2023, an estimated $65.8K.
Edwards Lifesciences made up 0.01% of Desjardins Global Asset Management's portfolio in Q4 2023, its #426 holding.
Desjardins Global Asset Management first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 9 quarters since.
Desjardins Global Asset Management's Edwards Lifesciences position peaked at $725K in Q4 2021.
1,244 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.